UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                          Date of Report: June 6, 2019
                        (Date of earliest event reported)


                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
               (Exact name of registrant as specified in charter)


                                    Colorado
                ------------------------------------------------
                  (State or other Jurisdiction of Incorporation
                                or Organization)


                         301 Commercial Road, Unit D
      000-54582                Golden, CO 80401                 46-5221947
--------------------   ---------------------------------    -------------------
   (Commission File    (Address of Principal Executive         (IRS Employer
       Number)              Offices and Zip Code)             Identification
                                                                  Number)


                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)


                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ] Written  communications  pursuant to Rule 425 under the  Securities Act (17
    CFR 230.425)

[ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications  pursuant  to  Rule  13e-14(c)  under  the
    Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

         Title of         Trading              Name of each exchange
        each class        Symbol(s)             on which registered
       -----------        --------             --------------------
           None             N/A                         N/A

Indicate by check mark whether the  Registrant is an emerging  growth company as
defined in Rule 405 of the  Securities  Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

Emerging Growth Company [ ]

If an emerging  growth  company,  indicate by check mark if the  Registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial  accounting  standards provided pursuant to Section 13a of the
Exchange Act. [ ]


<PAGE>


Item 1.01.  Entry Into A Material Definitive Agreement.

     On June 6, 2019,  United Cannabis  Corporation  (the  "Company")  signed an
agreement to supply CBD isolate  over the next 100 weeks to an  unrelated  third
party.

     The Agreement  provides that the purchase  price for the CBD isolate may be
adjusted by the mutual  agreement  of the parties.  If either  party  requests a
price  adjustment  in advance of the next week's  purchase,  and the other party
does not  agree to the  adjustment,  then the  order  for that week only will be
cancelled.

     If the third party  completes the purchase of the CBD isolate,  the Company
estimates  that this contract  will produce  revenues over the next two years of
approximately $42,000,000 for the Company.





                                       2
<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                    UNITED CANNABIS CORPORATION


Dated:  July 15, 2019               By:  /s/ John Walsh
                                         -------------------------------
                                         John Walsh
                                         Chief Financial Officer












                                       3
[{"type": "8-K", "sequence": "1", "filename": "form8k101cbdagree7-19.txt", "secsgml_size_bytes": 4562}]
{"company-data": {"conformed-name": "United Cannabis Corp", "cik": "0001436161", "assigned-sic": "2834", "irs-number": "261391338", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54582", "film-number": "19956028"}, "business-address": {"street1": "301 COMMERCIAL RD.", "street2": "UNIT D", "city": "GOLDEN", "state": "CO", "zip": "80401", "phone": "844-278-2420"}, "mail-address": {"street1": "301 COMMERCIAL RD.", "street2": "UNIT D", "city": "GOLDEN", "state": "CO", "zip": "80401"}, "former-company": {"former-conformed-name": "MySkin, Inc.", "date-changed": "20080528"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                          Date of Report: June 6, 2019
                        (Date of earliest event reported)

                           UNITED CANNABIS CORPORATION
                  -------------------------------------------
               (Exact name of registrant as specified in charter)

                                    Colorado
                ------------------------------------------------
                  (State or other Jurisdiction of Incorporation
                                or Organization)

                         301 Commercial Road, Unit D
      000-54582                Golden, CO 80401                 46-5221947
--------------------   ---------------------------------    -------------------
   (Commission File    (Address of Principal Executive         (IRS Employer
       Number)              Offices and Zip Code)             Identification
                                                                  Number)

                                 (303) 386-7321
                  -------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
              ----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:

[ ] Written  communications  pursuant to Rule 425 under the  Securities Act (17
    CFR 230.425)

[ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement  communications  pursuant  to  Rule  13e-14(c)  under  the
    Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

         Title of         Trading              Name of each exchange
        each class        Symbol(s)             on which registered
       -----------        --------             --------------------
           None             N/A                         N/A

Indicate by check mark whether the  Registrant is an emerging  growth company as
defined in Rule 405 of the  Securities  Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).

Emerging Growth Company [ ]

If an emerging  growth  company,  indicate by check mark if the  Registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial  accounting  standards provided pursuant to Section 13a of the
Exchange Act. [ ]
Item 1.01.  Entry Into A Material Definitive Agreement.

     On June 6, 2019,  United Cannabis  Corporation  (the  "Company")  signed an
agreement to supply CBD isolate  over the next 100 weeks to an  unrelated  third
party.

     The Agreement  provides that the purchase  price for the CBD isolate may be
adjusted by the mutual  agreement  of the parties.  If either  party  requests a
price  adjustment  in advance of the next week's  purchase,  and the other party
does not  agree to the  adjustment,  then the  order  for that week only will be
cancelled.

     If the third party  completes the purchase of the CBD isolate,  the Company
estimates  that this contract  will produce  revenues over the next two years of
approximately $42,000,000 for the Company.

                                       2
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                    UNITED CANNABIS CORPORATION

Dated:  July 15, 2019               By:  /s/ John Walsh
                                         -------------------------------
                                         John Walsh
                                         Chief Financial Officer

                                       3